VENDOR COMPARISON

Paradigm Peptide vs Polaris Peptides

Independent side-by-side comparison across the 3 peptides both vendors sell. Composite scores, lab quality, and verified pricing.

Paradigm Peptide

Research
B+
Score
7.4
Peptides
6
Tests
54

Top Retatrutide vendor by score (9.0 across 14 tests). Strong on metabolic peptides.

Paradigm Peptide full review →

Polaris Peptides

Research
B+
Score
7.6
Peptides
9
Tests
97

9 peptides with 97 lab tests. Tirzepatide and PT-141 grade A; Retatrutide drops to D due to wider score variance.

Polaris Peptides full review →

Side-by-side breakdown

PEPTIDE PARADIGM PEPTIDE POLARIS PEPTIDES WINNER
Ipamorelin
9.0 A (6 tests)
8.0 B+ (5 tests)
Paradigm Peptide
Tirzepatide
8.4 B+ (14 tests)
8.8 B+ (15 tests)
Polaris Peptides
Retatrutide
7.0 B (14 tests)
7.3 B (26 tests)
Polaris Peptides
GHK-Cu
(not sold)
8.8 B+ (8 tests)
Polaris Peptides only
Semaglutide
(not sold)
6.9 B (16 tests)
Polaris Peptides only
BPC-157
(not sold)
5.4 C (11 tests)
Polaris Peptides only

Which to choose

Across the 3 peptides both vendors sell, Paradigm Peptide scores higher on 1, Polaris Peptides scores higher on 1, and 1 are within 0.3 points (effectively tied). Polaris Peptides additionally sells GHK-Cu, Semaglutide, BPC-157; Paradigm Peptide does not.

Choose Paradigm Peptide for: Ipamorelin.

Choose Polaris Peptides for: Tirzepatide.

Either works for Retatrutide — composite scores are within 0.3 points.

Composite scores reflect lab quality, sentiment, COA transparency, reliability, and price. How we score.

Full profiles: Paradigm Peptide review · Polaris Peptides review